Covaxin-Induced Lymphocytic Myocarditis.

Authors :: Mittal N
Pawar D
Parmar K
Sly Z
Del Rio-Pertuz G
Ansari MM
Nair N
Source :: Cureus [Cureus] 2022 Jul 11; Vol. 14 (7), pp. e26759. Date of Electronic Publication: 2022 Jul 11 (Print Publication: 2022).
Publication Year :: 2022
Abstract: We report the case of a young adult male with endomyocardial biopsy-proven lymphocytic myocarditis following Covaxin administration. Covaxin differs from the mRNA vaccines in that it is an inactivated virus developed using the whole virion inactivated using the Vero cell platform. We successfully managed the patient with complete resolution of symptoms.<br />Competing Interests: The authors have declared that no competing interests exist.<br /> (Copyright © 2022, Mittal et al.)